Sensorineural hearing loss associated with ulcerative colitis. A case report.
Autoimmune sensorineural hearing loss was first described in 1979. This may be secondary to a systemic autoimmune disease, or in some cases, to a direct autoimmune insult to the labyrinth. A case of active ulcerative colitis and progressive sensorineural hearing loss responded to corticosteroid therapy.
D001327:Autoimmune Diseases / Q000150:complications*; D003093:Colitis, Ulcerative / Q000150:complications* / Q000188:drug therapy / Q000276:immunology; D003181:Complement C4 / Q000032:analysis; D003602:Cytotoxicity, Immunologic; D006319:Hearing Loss, Sensorineural / Q000150:complications* / Q000188:drug therapy / Q000276:immunology; D006801:Humans; D007070:Immunoglobulin A / Q000032:analysis; D007074:Immunoglobulin G / Q000032:analysis; D008214:Lymphocytes / Q000276:immunology; D008297:Male; D008875:Middle Aged; D012460:Sulfasalazine / Q000008:administration & dosage / Q000627:therapeutic use
D003181:Complement C4; D007070:Immunoglobulin A; D007074:Immunoglobulin G; D012460:Sulfasalazine